Phospholipid metabolism was studied in rat myocardial slices that were incubated under normoxia or hypoxia for up to 24 hours. Phospholipid degradation was prominent in hypoxic myocardium, particularly phosphatidylcholine, which markedly decreased after 24 hours of hypoxia. In contrast, lysophosphatidjlcholine increased. The mechanism of phospholipid degradation in hypoxic myocardium was studied. The highest activity for phospholipase A 2 among subcellular fractions was found in microsomal fraction. In hypoxic myocardium, this phospholipase A 2 activity markedly increased and had substrate specificity toward phosphatidylcholine and phosphatidylethanolamine. Phosphatidylcholine was slightly hydrolyzed in control myocardium, but it was markedly hydrolyzed in hypoxic myocardium. Phospholipase C activity was found in cytosol and had a high substrate specificity toward phosphatidylinositol. In hypoxic myocardium, its activity gradually decreased during hypoxic incubation. Prostacyclin biosynthesis was also determined. The synthesis of prostacyclin in hypoxic myocardial microsomes did not increase. These results suggest that hypoxia causes phospholipid degradation and activates phospholipase A 2 activity. {Circulation Research 1988;62:1175-1181) H igh levels of circulating free fatty acids have been observed in patients after myocardial infarction, 1 " 4 and elevated free fatty acid levels have been correlated with the appearance of ventricular arrhythmias. 3 Many aspects of the changes associated with myocardial ischemia have been intensively studied. 67 Abnormal lipid metabolism alters cardiac function by changing the cardiac cell membrane properties. These functional changes may contribute to decreased myocardial contractility, arrhythmia, and cell death that follow coronary artery occlusion. 8 Despite early functional changes in membrane properties that are responsible for the electrophysiological manifestation of ischemia, little is known about myocardial phospholipid metabolism. The possibility that lysophospholipids contribute to ischemic heart damage was first suggested by Hajidu et al. Lysophospholipid accumulation is caused by decreased lysophospholipase a c t i v i t y " ; however, the extent of the lysophosphatide increase in the ischemic heart is a matter of controversy.
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Recently, we showed that free fatty acid and prostacyclin [prostaglandin (PG)I14 2 ] are released from isolated heart during hypoxia; phospholipid degradation in canine ischemic myocardium has been also reported by Chien et al. But the mechanisms of phospholipid degradation and fatty acid release remain unclear.
This study was performed to determine the early and delayed effects of hypoxia on phospholipase activity and prostaglandin synthesis. We attempt to clarify the enzymatic mechanisms of phospholipid degradation leading to free fatty acid and PGI 2 releases in hypoxic myocardium.
Materials and Methods
Experimental Protocol
Experiments were carried out on male Wistar rats (200-300 g). The left ventricle was excised from rat heart. Blood was carefully washed out; and the left ventricle was cut along the longitudinal axis (about 1 mm thick) and sliced (about 3 x 10 mm). The slices were incubated for indicated periods at 37° C in 0.1 M HEPES, Krebs-Henseleit buffer (mM: NaCl 120, NaHCO 3 25, KC1 2 5.6, CaCl 2 2.5, NaHPO, 1.2, MgSO 4 1.2, glucose 11, pH 7.4) saturated with 95% O 2 -5% CO 2 (normoxic incubation) or 95% N 2 -5% CO 2 (hypoxic incubation). The myocardium, which was incubated under hypoxic or normoxic conditions for 24 hours, was used for assays unless otherwise mentioned. The pH of the incubation buffer was maintained at 7.4 during the 24-hour incubation. Six hearts were used for each incubation period.
For preparation of subcellular fractions, rat heart slices were incubated under hypoxic or normoxic conditions for up to 24 hours, and tissue was processed identically for normoxic and hypoxic myocardium. Myocardial slices were minced and homogenized for 60 seconds by a Polytron homogenizer (PT-10, Kinematica, Switzerland) in 5 volumes (vol/wt) of 0.1 M Tris-HCl (pH 7.4). The homogenate was centrifuged at 700g for 10 minutes, and the resultant supernatant was centrifuged at 9,000g for 20 minutes. The resultant pellet was washed twice with the same buffer and used as the mitochondrial fraction, and the supernatant was centrifuged at 105,000# for 60 minutes according to previously published methods. 16 The pellet was washed twice with the same buffer and suspended in 0.1 M Tris-HCl buffer (pH 8.0) and used for each assay as the microsomes. The resultant supernatant was centrifuged again at 105,000g for 60 minutes and used as the cytosomal fraction. Subcellular fractions of hypoxic myocardium were also prepared by the same procedure.
NADH-cytochrome c reductase was measured spectrophotometrically by the method of Sottocasa et al 17 as a marker enzyme of mitochondria and microsomes. /3-Glucuronidase was measured as a marker enzyme of lysosomes. 18 In mitochondrial and microsomal fractions, /3-glucuronidase activity was detected but was not detected in cytosomal fractions. These results show that there is a slight contamination of lysosomes into both mitochondrial and microsomal fractions, but there is no difference in these enzymes activities between normoxic and hypoxic incubations.
Prostaglandin Biosynthesis
PGI 2 was measured as 6-keto-prostaglandin F lQ (6keto-PGF| 0 ), which is its stable metabolite. The assay mixture contained 0.1 M Tris-HCl (pH 8.0), 0.2 mM L-tryptophane, 0.1 ptM hemoglobin, 20 /xM [l-l4 C]arachidonic acid (Amersham, Arlington Heights, Illinois), and 200 /xg microsomal protein in a total volume of 200 fx\. Assays were carried out at 37° C for 10 minutes, and the reactions were terminated with 30 /xl of IN HC1 according to methods previously described. 19 The reaction mixture was then extracted twice with 2 ml ethyl acetate, and the combined extracts were evaporated under a vacuum. The residues, taken up in a small volume of acetone, were quantitatively spotted on plastic silica gel G plates (Merck Sharpe & Dohme, West Point, Pennsylvania) along with authentic unlabeled prostaglandins (Sigma Chemical, St. Louis, Missouri) and arachidonic acid (Sigma) as the control. Plates were developed with either solvent system A, containing the organic phase from ethyl acetate/acetic acid/2,2,4-trimethylpentane/ water (110:20:50:100, vol/vol/vol/vol) or solvent system B, containing 1% acetic acid in ethyl acetate according to previous methods. The plate was placed in iodine vapor for color development. To separate prostaglandin E2 (PGE2) and prostaglandin F^ (PGF^) from thromboxane B 2 (TXBj) or 6-keto-PGF, a , the plates were first developed up to 15 cm from the origin; after drying, they were developed again 17 cm from the origin in solvent system B or A, respectively, according to previously published methods. Each plate was cut into small pieces and placed in counting vials. Radioactivity was measured by a liquid scintillation counter. Further identification of reaction products was done with high-performance liquid chromatography according to previous methods. The retention times of 6-keto-PGF ]a , TXB 2 , PGF^, and PGEj were 3, 5, 7, and 12 minutes, respectively.
Phospholipase A 2 Activity
A preliminary experiment determined that the optimal pH was 8.5. Nonradioactive phospholipids (Sigma Chemical) were added to radioactive phospholipids to adjust the specific activity of the substrate to 50,000 cpm/50 nmol. Each subcellular fraction was incubated with 50 nmol l-palmitoyl-2-[l-l4 C]arachidonylphos-phatidylethanolamine (Amersham) and 5 mM CaCl 2 in 0.1 M Tris HC1, pH 8.5, in 500 fi\ at 37° C for 1 hour according to previous methods. 16 The subcellular fractions were also incubated with 1,2-dioleoylphosphatidyl [U-l4 C]serine, l-stearyl-2-[l-14 C]arachidonylphosphatidylcholine, and l-stearyl-2-[l-l4 C]arachidonylphosphatidylinositol (Amersham) to determine the substrate specificity in the same assay conditions. The reaction was terminated by adding 4 ml chloroform/methanol ( 2 : 1 , vol/vol) according to the method of Folch et al. 23 The chloroform phase was removed and dried under a vacuum. The residues were applied to silica gel G plates and developed in solvent system B described above according to previous methods. 24 Zones corresponding to the authentic phospholipids and to arachidonic acid were cut into small pieces. The arachidonic acid zone was counted as arachidonic acid released from phospholipids according to previous methods. 23 
Phospholipase C Activity
The preliminary study determined that the optimal pH for phospholipase C was 7.0. Each subcellular fraction was incubated with [ 14 C]arachidonic acidlabeled phospholipids (50,000 cpm/20 nmol) in 0.1 M Tris-HCl, pH 7.0, for 2 minutes at 37° C. The released diglyceride and free arachidonic acid were extracted by the method of Folch et al. 23 The chloroform phase was pooled and evaporated under vacuum. The residues were applied to thin-layer chromatography, which was developed in isopropyl ether/acetic acid (96:4, vol/vol) and then again in a solvent system containing petroleum ether/diethyl ether/acetic acid (90:10:1, vol/vol/vol). The respective spots of monoglyceride, diglyceride, triglyceride, and arachidonic acid were scraped, counted with a scintillation spectrometer, and analyzed according to previous studies. 20 
Other Methods
Protein was determined by the method of Lowry et al 26 with bovine serum albumin as the standard.
Myocardial phospholipids and free fatty acid were extracted by the method of Folch et al 23 and applied to silica gel thin-layer plates developed with chloroform/ methanol/glacial acetic acid/water (25:15:4:2, vol/ vol/vol/vol) at 4° C. The authentic spots (LysoPC, SM, PC, PI, PS, PE, and fatty acid; see Table 1 ) were made visible in ultraviolet light after spraying a solution of 2,7-dichroIo-fiuorescein. The zone corresponding to phospholipids and fatty acid was scraped. Phospholipids were determined by analyzing the phosphorus content by the method of Bartlett. 27 Fatty acid methyl esters were prepared by a borontrifluoridemethanol reagent, according to previous methods 28 and analyzed by gas liquid chromatography with a column (0.3 X 200 cm) of 3% ethylene glycol succinate silicone-X on Chromosorb W (80-100 mesh) according to previous methods. 25 -29 Myocardial lactate concentration was determined by the method of Gutmann and Wahlefeld. 30 
Statistical Analysis
Triplicate samples were analyzed in all experiments. Results are expressed as mean±SEM. The Student's / test was used to analyze the results, and significance was considered a t p < 0 . 0 5 .
Results
Parameter of Myocardial Hypoxia
Myocardial content of lactate was 5.3 ± 0 . 3 //.mol/g wet wtin 24-hour normoxic incubation, and 26.5 ±0.3 /imol/g wet wt in 24-hour hypoxic incubation. There was a fivefold increase in tissue lactate content in the hypoxic versus normoxic myocardium at 24 hours of incubation. Table 1 lists the percent compositions of phospholipids in 24-hour normoxic and hypoxic myocardium. Normoxic incubation was used as a control to verify that the degradation of phospholipids was not caused by autolysis. In hypoxic myocardium, lysophosphatidylcholine increased, and phosphatidylcholine (PC) decreased compared with that of control myocardium. Total phospholipid content in hypoxic myocardium decreased about 40% compared with that of control. In the fatty acid composition of phospholipids, arachidonic acid decreased (Table 1 ). This result shows that arachidonic acid in hypoxic myocardium was released into incubation buffer.
Phospholipids and Arachidonic Acid in Hypoxic Myocardium
Prostacyclin Biosynthesis
As shown in Figure 1 , the synthesis of 6-keto-PGF )Q did not change during the first 2 hours; however, afterwards it gradually decreased during hypoxia, though its synthesis during normoxia was well preserved.
Subcellular Localization of Phospholipase Activity
Subcellular localization of phospholipase A 2 activity was determined to prepare the crude enzyme for further experiments with phosphatidylethanolarhine (PE) as the substrate. Microsomal phospholipase A 2 activity was highest in control myocardium. This microsomal activity was markedly enhanced in 24-hour hypoxic myocardium (Figure 2A ). As shown in Figure 2B , myocardial phospholipase C activity existed in the cytosol.
Substrate Specificity of Phospholipase
Substrate specificity of phospholipase was determined to elucidate the mechanism of phospholipid degradation. Microsomal phospholipase A 2 had a substrate specificity toward PE in control myocardium, but in 24-hour hypoxic myocardium, PC was hydrolyzed 6.3 times compared with that in control. The hydrolysis of PE was highest in hypoxic myocardium; the rate of increased PE-hydrolysis in hypoxic myocardium was 2.6 times that of control ( Figure 3A) . On the other hand, phospholipase C activity had a high substrate specificity toward phosphatidylinositol (PI). In 24-hour hypoxic myocardium, phospholipase C activity slightly decreased ( Figure 3B ).
Time Course of Phospholipase Activity
The time course of phospholipase activity during hypoxic incubation was determined to clarify the early and delayed metabolism of phospholipids. As shown in Figure 4A , phospholipase A 2 activity began to increase 2 hours after hypoxic incubation was initiated and increased for at least 24 hours. In normoxic incubation, phospholipase A 2 activity did not change for 24 hours. In hypoxic incubation, the time course revealed that phospholipase C activity did not change during the first 2 hours but that afterwards it gradually decreased ( Figure 4B ).
Discussion
Though our hypoxic myocardium model was an isolated and nonbeating heart, the degradation of phospholipids was quite similar to canine ischemic myocardium. 15 We attempted to determine whether phospholipase A 2 and/or C activities increase under these conditions. Earlier reports show that lysophospholipids accumulate in ischemic myocardium 910 and suggest that phospholipase A 2 may be activated in hypoxic myocardium. But Gross and Sobel" reported that the accumulation of lysophospholipid was caused by decreased lysophospholipase activity. In contrast, other researchers showed the degradation of phospholipids in ischemic liver 31 and in ischemic myocardium 13 and suggested that phospholipase A 2 is activated in ischemic liver and heart. But phospholipase A 2 had been neither determined nor characterized. Our experiment showed that phospholipase A 2 was activated in hypoxic myocardium. In control (preincubation) myocardium, phospholipase A 2 had a substrate specificity toward PE, and in 24-hour hypoxic myocardium, its activity was broadly increased for all classes of phospholipids, especially, and PE and PC were markedly hydrolized. It is quite interesting that there is little PC hydrolysis in the control and that this phospholipase A 2 had high substrate specificity to PC in 24-hour hypoxia. Further investigations, such as the purification of phospholipase A 2 , are under way to elucidate the mechanism of phospholipase A 2 activation.
Phospholipase C in rat myocardium was first reported by Hostetler and Hall. 32 Using PC as the substrate, they found that the activity of phospholipase C in heart was lower than in other organs. Our experiments showed that phospholipase C in myocardium has high substrate specificity toward PI. Recently, Pi-specific phospholipase C has been noticed in the relation between prostaglandin synthesis and PI response. 33 Several different agonists are known to alter PI metabolism while stimulating tissue responses as varied as secretion, muscle contraction, and mitogenesis. 34 Both increased degradation and increased synthesis of PI have been observed, sometimes in a single response system. The concept has emerged that some agonists act through a common mechanism involving Pl-specific phospholipase C stimulation and the subsequent conversion of released diglyceride to phosphatidic acid, and then cytosine diphosphate-diglyceride and PI. Whether this mechanism is applicable to all systems showing a "PI response" remains to be established. The diglyceride formed by the phospholipase C reaction is hydrolyzed to monoglyceride and arachidonic acid. This diglyceride regulates protein kinase C," while phosphatidic acid stimulates the influx of Ca 2+ . Our experiments showed that phospholipase C activity gradually decreased during 24 hours of hypoxia. These phenomena may alter myocardial contractility.
The heart can metabolize arachidonic acid into sev-eral prostaglandins, 36 the most prominent of which is PGI 2 . 37 The rate of prostaglandin synthesis in the heart is augmented by hormone stimulation, 38 anoxia, M>39 and ischemia. 40 In earlier experiments, l4 ' 39 ' 40 PGI 2 release from hypoxic or ischemic heart increased. On the other hand, our experiment showed that the enzyme activity of PGI 2 synthesis (cyclooxygenase and/or PGI 2 synthetase activity) decreased in hypoxic myocardium. There are differences between our experimental condition and others. The present experiments were performed with microsomes. They had used physiologically beating hearts. But these data suggest that the increased phospholipase A 2 sufficiently contributed to the substrate for PGI 2 synthesis, even when enzyme activity of PGI 2 synthesis was slightly decreased in hypoxia. Our results showed that microsomal PGI 2 synthesis did not increase in hypoxic myocardium.
Since there is a possibility that lysophospholipids inhibit prostaglandin synthesis in some cases, the increased phospholipase A 2 activity might result in decreased prostaglandin synthesis. But increased phospholipase A 2 activity could produce the substrate for PGI 2 synthesis and arachidonic acid during hypoxia and could compensate the decreased enzyme activity of PGI 2 synthesis. Phospholipase A 2 activity may be a rate-limiting step for prostacyclin synthesis in hypoxic myocardium.
If the degradation of phospholipid degradation is closely linked to the development of cell injury, the development antl application of specific phospholipase inhibitors may be of value in protecting against cellular deterioration during hypoxia. In addition, this study of microsomal phospholipase may prove useful in studying the biochemical link between hypoxia and phospholipid degradation. However, to assess the full significance of our findings in vitro, further studies are required under more physiological conditions in vivo. In our laboratory, further studies are under way with cultured myocardial cells.
